[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Embecta Corp (EMBC)

Embecta Corp (EMBC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 196,376
  • Shares Outstanding, K 59,328
  • Annual Sales, $ 1,080 M
  • Annual Income, $ 95,400 K
  • EBIT $ 269 M
  • EBITDA $ 329 M
  • 60-Month Beta 0.84
  • Price/Sales 0.19
  • Price/Cash Flow 0.87
  • Price/Book N/A

Options Overview Details

View History
  • Implied Volatility 129.80% (-4.59%)
  • Historical Volatility 59.40%
  • IV Percentile 92%
  • IV Rank 54.81%
  • IV High 202.64% on 05/15/26
  • IV Low 41.45% on 07/11/25
  • Expected Move (DTE 16) 0.00 (0.00%)
  • Put/Call Vol Ratio 0.15
  • Today's Volume 31
  • Volume Avg (30-Day) 70
  • Put/Call OI Ratio 0.08
  • Today's Open Interest 6,253
  • Open Int (30-Day) 6,124
  • Expected Range 3.26 to 3.26

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Sell
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $0.26
  • Number of Estimates 1
  • High Estimate $0.26
  • Low Estimate $0.26
  • Prior Year $1.12
  • Growth Rate Est. (year over year) -76.79%

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.01 +8.31%
on 06/23/26
3.54 -7.91%
on 06/02/26
-0.12 (-3.55%)
since 05/29/26
3-Month
2.77 +17.69%
on 05/20/26
9.90 -67.07%
on 04/20/26
-5.58 (-63.12%)
since 03/30/26
52-Week
2.77 +17.69%
on 05/20/26
15.55 -79.04%
on 09/17/25
-6.43 (-66.36%)
since 06/30/25

Most Recent Stories

More News
Embecta Corp. (EMBC) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

BENSALEM, Pa. , June 30, 2026 /PRNewswire/ -- The Law Offices of Howard G. Smith announces that investors with substantial losses have opportunity to lead the securities fraud class action...

EMBC : 3.26 (-1.51%)
$EMBC Notification: Embecta Accused of Misrepresentations about its Insulin Pen Issues in Securities Fraud Class Action

A securities fraud class action lawsuit has been filed on behalf of Embecta investors after its stock plummeted over 57% because Embecta allegedly misled investors regarding the strength of its...

EMBC : 3.26 (-1.51%)
EMBC Investors Have Opportunity to Lead Embecta Corp. Securities Fraud Lawsuit

NEW YORK , June 29, 2026 /PRNewswire/ --

EMBC : 3.26 (-1.51%)
Embecta Corp. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - EMBC

LOS ANGELES , June 29, 2026 /PRNewswire/ --  The DJS Law Group reminds investors of a class action lawsuit against Embecta Corp. ("Embecta" or "the Company") (NASDAQ: EMBC ) for violations...

EMBC : 3.26 (-1.51%)
EMBC Investors Have Opportunity to Lead Embecta Corp. Securities Fraud Lawsuit with the Schall Law Firm

LOS ANGELES , June 29, 2026 /PRNewswire/ --  The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Embecta Corp. ("Embecta"...

EMBC : 3.26 (-1.51%)
Deadline Alert: Embecta Corp. (EMBC) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit

Glancy Prongay Wolke & Rotter LLP reminds investors of the upcoming August 17, 2026 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who...

EMBC : 3.26 (-1.51%)
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Embecta Corp. of Class Action Lawsuit and Upcoming Deadlines - EMBC

NEW YORK , June 25, 2026 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Embecta Corp. ("Embecta" or the "Company") (NASDAQ: EMBC).   Such investors...

EMBC : 3.26 (-1.51%)
Deadline Approaching: Embecta Corp. (EMBC) Shareholders Who Lost Money Urged To Contact Law Offices of Howard G. Smith

Law Offices of Howard G. Smith reminds investors of the upcoming August 17, 2026 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased Embecta...

EMBC : 3.26 (-1.51%)
Embecta Corp. (EMBC) Faces Securities Class Action for Allegedly Concealing Competitive Threats to Pen Needle Business -- HBSS

SAN FRANCISCO , June 25, 2026 /PRNewswire/ -- Embecta Corp. ( NASDAQ: EMBC ) faces a securities class action lawsuit, which seeks to represent investors who purchased or acquired Embecta common...

EMBC : 3.26 (-1.51%)
EMBC Investors Have Opportunity to Lead Embecta Corp. Securities Fraud Lawsuit with the Schall Law Firm

LOS ANGELES , June 25, 2026 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Embecta Corp. ("Embecta" or...

EMBC : 3.26 (-1.51%)

Business Summary

Embecta Corp. is a pure-play diabetes care company. Embecta is based in FRANKLIN LAKES, N.J.

See More

Key Turning Points

3rd Resistance Point 3.45
2nd Resistance Point 3.39
1st Resistance Point 3.33
Last Price 3.26
1st Support Level 3.20
2nd Support Level 3.14
3rd Support Level 3.08

See More

52-Week High 15.55
Fibonacci 61.8% 10.67
Fibonacci 50% 9.16
Fibonacci 38.2% 7.65
Last Price 3.26
52-Week Low 2.77

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.